CD44 and glioblastoma: qPCR analysis showed that the expression of stemness genes, including OCT4, NANOG, SOX2, and BMI1, was higher in CD44‐positive GBM‐MG1 cells than in CD44‐negative GBM‐MG1 cells (Figure 3D).